Identification of Drugs Inducing Phospholipidosis by Novel in vitro Data
Open Access
- 3 September 2012
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 7 (11), 1925-1934
- https://doi.org/10.1002/cmdc.201200306
Abstract
Drug-induced phospholipidosis (PLD) is a lysosomal storage disorder characterized by the accumulation of phospholipids within the lysosome. This adverse drug effect can occur in various tissues and is suspected to impact cellular viability. Therefore, it is important to test chemical compounds for their potential to induce PLD during the drug design process. PLD has been reported to be a side effect of many commonly used drugs, especially those with cationic amphiphilic properties. To predict drug-induced PLD in silico, we established a high-throughput cell-culture-based method to quantitatively determine the induction of PLD by chemical compounds. Using this assay, we tested 297 drug-like compounds at two different concentrations (2.5 μM and 5.0 μM). We were able to identify 28 previously unknown PLD-inducing agents. Furthermore, our experimental results enabled the development of a binary classification model to predict PLD-inducing agents based on their molecular properties. This random forest prediction system yields a bootstrapped validated accuracy of 86 %. PLD-inducing agents overlap with those that target similar biological processes; a high degree of concordance with PLD-inducing agents was identified for cationic amphiphilic compounds, small molecules that inhibit acid sphingomyelinase, compounds that cross the blood–brain barrier, and compounds that violate Lipinski’s rule of five. Furthermore, we were able to show that PLD-inducing compounds applied in combination additively induce PLD.Keywords
This publication has 108 references indexed in Scilit:
- Qualitative prediction of blood–brain barrier permeability on a large and refined datasetJournal of Computer-Aided Molecular Design, 2011
- Identification of Novel Functional Inhibitors of Acid SphingomyelinasePLOS ONE, 2011
- Molecular Imaging of Intracellular Drug–Membrane Aggregate FormationMolecular Pharmaceutics, 2011
- Effect of Phospholipidosis on the Cellular Pharmacokinetics of ChloroquineThe Journal of pharmacology and experimental therapeutics, 2010
- DrugBank 3.0: a comprehensive resource for 'Omics' research on drugsNucleic Acids Research, 2010
- Predicting Phospholipidosis Using Machine LearningMolecular Pharmaceutics, 2010
- Prediction of passive blood–brain partitioning: Straightforward and effective classification models based on in silico derived physicochemical descriptorsJournal of Molecular Graphics and Modelling, 2010
- The role of negatively charged lipids in lysosomal phospholipase A2 functionJournal of Lipid Research, 2009
- Quantitative modeling of selective lysosomal targeting for drug designEuropean Biophysics Journal, 2008
- Lysosomal Phospholipase A2 and PhospholipidosisMolecular and Cellular Biology, 2006